Welcome to the Official Web Site of the
International Association for Pain and Chemical Dependency
The International Association for Pain and Chemical Dependency is an international organization dedicated to promoting appropriate and effective treatment for all patients with pain, including individuals with substance abuse, mental health or other co-occurring problems that may make treatment more challenging. The association encourages cooperation among professionals in the fields of health care, policy and regulation, law enforcement, law, politics and the media to improve communication and education for the appropriate use of controlled substances in pain treatment.
To learn more about the IAPCD click here.
Resource Center: Developing a Risk Evaluation and Mitigation Strategy (REMS) for Extended Release Opioids – Milestones and Materials from the Food and Drug Association (FDA) Initiative
As a member of the global community of professionals involved in managing care at the interface of pain and dependency, you understand that our institutions and organizations are dealing with significant challenges on numerous fronts.
Access to medications that alleviate painful suffering used to be the focus mainly in emerging countries, but that is no longer the case. Now, in the industrialized nations, the rising incidence and prevalence of opioid diversion, misuse, abuse, and addiction has triggered regulatory interventions that may result in diminished access to pain management therapies for patients in need.
The only resolution to this cyclical conundrum is for those who once collaborated to win the right to fundamental pain management to come together again to advocate, with equal passion, the mitigation of unwanted risk in the context of chronic pain treatment.
On behalf of IAPCD members, our administrative supporters, MediCom Worldwide and Corona Productions have been working diligently to monitor the development of risk management regulations related to extended release opioids. One result of their activities is this new resource. Here you can access
- Scientific and clinical slide presentations complete with data
- Tutorial webinar about what REMS is all about
- Notices of upcoming activities
- Webcasts of meetings between FDA and industry
- Links that allow practitioners to contribute their data and perspectives directly to the FDA as the new regulations are being formulated.
IAPCD is also represented on a stakeholder group, The Pain Care Forum, that closely monitors and comments on the activities as they are evolving. Members also can access materials of interest from that group. |
